Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Key facts
Counted staff
19
self-reported 2–10 band
Founded
2020
6 years
Legal entities
None matched
Office countries
2
3 addresses
Funding rounds
5
Grant · Sep 2025 · US$ 2.0M
Company type
Privately Held
self-reported
Description
Diag-Nose.io, founded in 2020 and headquartered in Melbourne, Australia, is a biotechnology company focused on translating the complexities of the unified airway into precision diagnostic and drug discovery solutions.
Their precision medicine technology combines advanced proteomics, computational biology, and AI (machine learning) to create a scalable respiratory biology model. This innovation aims to help clinicians prescribe the right treatments faster and enable researchers to accelerate the development of new therapies.
The company’s flagship platform, RhinoMAP™, leverages proteomic data to predict respiratory disease activity, monitor therapy response and predict treatment efficacy in advance, with an initial focus on anti-Th2 biologics.
Locations
2
Countries with an office address3 addresses on record
AustraliaprimaryUnited States
Country footprint
Show as table · Offices in 2 countries
| Countries | 2 |
|---|---|
| Primary country | AU |
All codes: AU US
Addresses
- AUMelbourne, VIC 3207Primary
- USBethlehem, Pennsylvania 18017
- USHouston, Texas 77030
Grid intelligence Members
Funding
Rounds5
Round typeGrant · non-equity funding
Amount (USD)2,000,000
Stage rank1
Investors named1
Since last round4 mo
Funding
Show as table · 5 funding rounds
| Rounds | 5 |
|---|---|
| Axis | 2020 to 2026 |
| Grant · 15 Sep 2025 | US$ 2.0M |
Dated rounds only. The axis ends at the date this profile was last observed, not at today.
Signals & hiring
Hiring, headcount and registry-change signals, streamed to members.
Latest signal
Hiring activity
Headcount trend
Financials
Registry-filed capital and financial indicators, standardised by TheGrid.
Paid-up capital
Fiscal period
Registered charges
Revenue
Profit / loss
People & contacts
4 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
Counts only. No names are stored here, and none are served.
FAQ
How many people work at Diag-Nose.io?
The record holds 19 counted staff profiles at January 2026, above the self-reported 2–10 band.
Where does Diag-Nose.io have offices?
Three addresses on record across 2 countries. Primary: Melbourne, VIC 3207.
Has Diag-Nose.io raised funding?
Five rounds. Latest 15 September 2025: grant, US$2,000,000, investor Cooperative Research Centre Projects.
Which companies are listed alongside Diag-Nose.io?
22 profiles list Diag-Nose.io as a peer — 94th percentile in Biotechnology Research. It lists ten peers of its own. Medow Health and MyGigsters list it back.